VOLITIONRX LTD
For the period ended Dec 31, 2023. Filed Mar 25, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 25, 2024
VNRX$0.20+2.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(Expressed in United States Dollars, except share numbers)
| December 31, | December 31, | |
|---|---|---|
| 2023 | 2022 | |
| $ | $ | |
| ASSETS | ||
| Current Assets | ||
| Cash and cash equivalents | 20,729,983 | 10,867,050 |
| Accounts receivable | 242,617 | 72,609 |
| Prepaid expenses | 521,370 | 784,920 |
| Other current assets | 360,125 | 447,566 |
| Total Current Assets | 21,854,095 | 12,172,145 |
| Property and equipment, net | 5,523,013 | 5,393,012 |
| Operating lease right-of-use assets | 549,504 | 619,392 |
| Intangible assets, net | 23,886 | 110,505 |
| Total Assets | 27,950,498 | 18,295,054 |
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
| Current Liabilities | ||
| Accounts payable | 3,211,287 | 3,043,008 |
| Accrued liabilities | 3,928,761 | 2,872,247 |
| Deferred revenue | 23,000,000 | 10,000,000 |
| Management and directors’ fees payable | 59,625 | 71,119 |
| Current portion of long-term debt | 1,207,007 | 1,066,700 |
| Warrant liability | 126,649 | - |
| Current portion of financing lease liabilities | 48,570 | 46,014 |
| Current portion of operating lease liabilities | 199,323 | 245,163 |
| Current portion of grant repayable | 55,855 | 41,836 |
| Total Current Liabilities | 31,837,077 | 17,386,087 |
| Long-term debt, net of current portion | 3,624,860 | 2,779,240 |
| Finance lease liabilities, net of current portion | 400,022 | 436,132 |
| Operating lease liabilities, net of current portion | 378,054 | 400,091 |
| Grant repayable, net of current portion | 422,707 | 420,466 |
| Total Liabilities | 36,662,720 | 21,422,016 |
| Stockholders' Deficit | ||
| Common stock | ||
| Authorized: 100,000,000 shares of common stock, at $0.001 par value | ||
| Issued and outstanding: 81,898,321 shares and 57,873,379 shares, respectively | 81,898 | 57,873 |
| Additional paid-in capital | 194,448,414 | 164,397,468 |
| Accumulated other comprehensive income | 243,940 | 227,097 |
| Accumulated deficit | (202,576,507) | (167,257,429) |
| Total VolitionRx Limited Stockholders' Deficit | (7,802,255) | (2,574,991) |
| Non-controlling interest | (909,967) | (551,971) |
| Total Stockholders’ Deficit | (8,712,222) | (3,126,962) |
| Total Liabilities and Stockholders’ Deficit | 27,950,498 | 18,295,054 |
| (The accompanying notes are an integral part of these consolidated financial statements) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.